| Name | Title | Contact Details |
|---|
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.
District Health Department #2 is a government administration organization that provides leadership in promoting environmental and personal health through health promotion, disease detection, disease prevention, education, and regulation in hopes of a h...
Interstate Blood Bank Inc is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Scienomics Group is a Greenwich, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Provides private mortgage insurance to residential mortgage lenders, including mortgage bankers, mortgage brokers, commercial banks, and savings institutions. (Nasdaq:TGIC).